KRAS and neoplasm: Taken together with the enrichment for EGFR and KRAS mutations in the NSD and SD trajectories respectively, this finding is in agreement with our previous work showing shorter latency in KRAS mutant tumours and longer latency in EGFR mutant tumours, both of which were found to be stronger associations in NS-LUAD8.